CTCBIO 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Mingoo Lee

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	12.1%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	데이터 없음

최근 관리 업데이트

Recent updates

CTCBIO's (KOSDAQ:060590) Shareholders Are Down 64% On Their Shares

Mar 15

Is CTCBIO (KOSDAQ:060590) Using Too Much Debt?

Jan 21

Would Shareholders Who Purchased CTCBIO's (KOSDAQ:060590) Stock Five Years Be Happy With The Share price Today?

Nov 29

CEO

Mingoo Lee (63 yo)

no data

테뉴어

Mr. Mingoo Lee serves as Associate Director at The Bridge, Inc.

CTCBIO 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Insufficient new directors

Insufficient new directors

Recent updates

Investor sentiment improves as stock rises 24%

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 15%

Now 22% undervalued

Investor sentiment improves as stock rises 18%

Insufficient new directors

Investor sentiment deteriorated over the past week

Insufficient new directors

CTCBIO Inc. announced that it has received KRW 9.999985977 billion in funding from Bridge Co., Ltd., Hwail Pharmaceutical Co.,Ltd.

CTCBIO Inc. announced that it expects to receive KRW 9.999985977 billion in funding from Bridge Co., Ltd., Hwail Pharmaceutical Co.,Ltd.

CTCBIO's (KOSDAQ:060590) Shareholders Are Down 64% On Their Shares

New 90-day low: ₩6,800

Is CTCBIO (KOSDAQ:060590) Using Too Much Debt?

New 90-day low: ₩7,240

Would Shareholders Who Purchased CTCBIO's (KOSDAQ:060590) Stock Five Years Be Happy With The Share price Today?

New 90-day low: ₩7,320

CTCBIO Inc. announced that it has received KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Daewoo Co., Ltd., Shinhan Financial Investment Co., Ltd

CTCBIO Inc. announced that it expects to receive KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Daewoo Co., Ltd., Shinhan Financial Investment Co., Ltd

New 90-day low: ₩7,780

CEO

테뉴어